Please ensure Javascript is enabled for purposes of website accessibility

Why GoPro, AngioDynamics, and Resources Connection Slumped Today

By Dan Caplinger – Oct 3, 2019 at 4:57PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Despite solid gains for most major benchmarks, these companies missed out.

Thursday was a volatile day on Wall Street, but markets generally turned higher by the end of the session. Despite ongoing concerns about the future direction of the U.S. economy, there are still a number of factors pointing toward continued expansion and a low chance of a recession in the immediate future. Even so, bad news hit some individual companies, sending their shares down. GoPro (GPRO 3.25%), AngioDynamics (ANGO -0.24%), and Resources Connection (RGP 1.49%) were among the worst performers. Here's why they did so poorly.

GoPro warns on new camera delays

Shares of GoPro sank 19% after the action-camera maker warned that it would suffer production delays for one of its new product releases. The company had just announced its HERO 8 Black camera for the holiday season, but a late-stage hiccup in the process means that GoPro will have to ship the new product in the fourth quarter rather than in the third quarter. As a result, GoPro cut its revenue growth projections by 3 percentage points, setting a new range of just 6% to 9%. Given how optimistic investors were about the release, news of the delay crushed morale for many of those following the stock.

View of person on bike wearing orange pants on a mountain trail with peaks in distance, taken from a mounted camera.

Image source: GoPro.

AngioDynamics makes a buy

AngioDynamics saw its stock drop 14% after the medical device maker released its latest financial results and announced an acquisition. Revenue rose just 3% year over year, although the company cited ongoing progress in a study for its NanoKnife product line for use in treating patients with pancreatic cancer. AngioDynamics also said it had acquired Eximo Medical in a deal that will pay Eximo $46 million in cash, with milestone payments of up to $20 million more. Eximo's products will boost AngioDynamics' overall portfolio, but investors are concerned about how the costs of launching those products will hurt earnings in the short run.

Resources Connection gets dumped

Finally, shares of Resources Connection fell 10%. The consulting company said that revenue in its fiscal first quarter was down almost 4% from year-ago levels, resulting in a double-digit-percentage decline in net income. CEO Kate Duchene explained that the consultant "engaged in decisive actions" that should lead to better financial performance over the long run, including an acquisition, a sale, and a closure of one of its offices. Resources Connection hasn't made a lot of progress toward sustained growth lately, and investors appear increasingly impatient to see better results from the company.

Dan Caplinger has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Resources Connection, Inc. Stock Quote
Resources Connection, Inc.
$18.34 (1.49%) $0.27
AngioDynamics, Inc. Stock Quote
AngioDynamics, Inc.
$20.41 (-0.24%) $0.05
GoPro, Inc. Stock Quote
GoPro, Inc.
$5.09 (3.25%) $0.16

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/03/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.